Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: J Invest Dermatol. 2020 Oct 13;141(5):1286–1296.e4. doi: 10.1016/j.jid.2020.09.017

Figure 3. C48/80, codeine, and SP trigger rapid downregulation of MRGPRX2 cell surface expression in skin-derived MCs intracellular accumulation of MRGPRX2.

Figure 3.

(a, b) Cultured skin-derived MCs were stimulated for the times indicated (10 µg/ml of C48/80, 30 µM of SP, 50 µg/ml of codeine). (a) MRGPRX2 surface expression (net MFI, Figure 1) plotted as a function of time; mean ± SEM and n = 9. *P < 0.05; **P < 0.01 versus C48/80; #P < 0.05 versus codeine. (b) Representative histograms of a; red: isotype, blue: MRGPRX2. (c) Intracellular MRGPRX2 expression by flow cytometry and fluorescence microscopy (on cell permeabilization, left panel) in comparison with MRGPRX2 at the cell surface (intact cells, right panel) at 1 hour after codeine or PBS treatment (control); one representative of n = 3. Bar = 25 µm. C48/80, compound 48/80; h, hour; MC, mast cell; MFI, mean fluorescence intensity; SP, substance P.